Medmen Signs Term Sheets to Divest Arizona and Illinois Assets, Reduces Financing

Medmen Enterprises (CSE: MMEN) this morning announced progress in its recent decision to sell certain non-core assets of its US holdings. In accordance with that plan, the firm has entered a non-binding term sheet to sell its three Arizona vertical licenses, as well as a binding term sheet to sell a cultivation and manufacturing license in Illinois.

Cumulatively Medmen expects to generate approximately US$54 million from the sale of these assets which have been labelled as being “non-core.” However, specific terms of the transactions, including individual values or estimated closing dates were not provided. Only the combined sales figure was included in this mornings news release.

Definitive documentation has yet to be signed for the asset sales.

Separately, Medmen has also reduced its previously announced US$27 million financing with Wicklow Capital as a result of acquiring the term sheets for non-core assets. In a move that is rare for the company, Medmen has allegedly reduced the capital figure to US$20 million to “limit dilution to shareholders.” The price per share for the equity financing remains at US$0.43, resulting in 46,962,648 additional Class B common shares hitting the market. The financing will see funds put towards general corporate purposes as well as retail expansion plans.

The equity placement is expected to close in “one or more tranches” in the “coming days.”

Should all sales and financings go through, Medmen Enterprises will see a cash infusion of US$74 million on a gross basis.

Medmen Enterprises last traded at C$0.69 on the CSE.


Information for this briefing was found via Sedar and MedMen Enterprises. The author has no affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Medmen: Canaccord Raises Price Target, Rating After Q4 Performance

On September 23, Medmen Enterprises (CSE: MMEN) reported their fiscal fourth-quarter financial results. The company...

Saturday, September 25, 2021, 01:05:00 PM

MedMen Enterprises Chief Revenue Officer Resigns From Role

MedMen Enterprises (CSE: MMEN) is down a member of management. The firm announced late Friday...

Sunday, February 13, 2022, 11:14:00 AM

Tilray Makes Move Into US Cannabis Market Via Medmen Convertible Notes

It appears that the rumours surrounding Tilray’s (NASDAQ: TLRY) focus on the US cannabis market...

Tuesday, August 17, 2021, 04:30:09 PM

MedMen To Appoint New Independent Board At Gotham Green’s Discretion

Following Medmen Enterprises’ (CSE: MMEN) horrendous financials filed yesterday for fiscal 2019, the firm announced...

Tuesday, October 29, 2019, 09:35:35 AM

Tilray Sees Gotham Green Look To Sell Recently Acquired Shares

It appears that Gotham Green Partners has approximately zero interest in being a shareholder of...

Monday, September 20, 2021, 08:32:00 AM